Effect of Berberine on the Proinflammatory Cytokines Production in Mice |
Chung, Su-Ryoung
(Department of Internal Medicine, Dong Eui Medical Center, Dong Eui University)
Choi, Myung-Won (Department of Microbiology, Kosin University College of Medicine) Park, In-Dal (Department of Microbiology, Kosin University College of Medicine) Kim, Kwang-Hyuk (Department of Microbiology, Kosin University College of Medicine) |
1 | Anis, K. V., N. V. Rajeshkumar, and R. Kuttan. 2001. Inhibition of chemical carcinogenesis by berberine in rat and mice. J. Pharm. Pharmacol. 53, 763-768. DOI |
2 | Creasey, W. A. 1979. Biochemical effects of berberine. Biochem. Pharmacol. 28, 1081-1084. DOI |
3 | Iizuka, N., K. Miyamoto, K. Okita, A. Tangoku, H. Hayashi, S. Yoshino, T. Abe, T. Morioka, S. Hazama, and M. Oka. 2000. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 148, 19-25. DOI |
4 | Iizuka, N., K. Miyamoto, S. Hazama, S. Yoshino, K. Yoshimura, K. Okida, T. Hukumoto, S. Yamamoto, A. Tangoku, and M. Oka. 2000. Anticachectic effect of Coptidis rhizoma, an antiinflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett. 158, 35-41. DOI |
5 | Zhao, W., Z. X. Zhou, W. J. Kong, and J. D. Jiang. 2008. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. Biomed. Pharmacother. 62, 730-731. DOI |
6 | Sun, Y., K. Xun, Y. Wang, and X. Chen. 2009. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20, 757-769. DOI ScienceOn |
7 | Lee, C. H., J. C. Chen, C. Y. Hsiang, S. L. Wu, H. C. Wu, and T. Y. Ho. 2007. Berberine suppresses inflammatory agents-induced interleukin-1 and tumor necrosis factor- productions via the inhibition of IB degradation in human lung cells. Pharmacol. Res. 56, 193-201. DOI |
8 | Liu, Y., H. Yu, C. Zhang, Y. Cheng, L. Hu, X. Meng, and Y. Zhao. 2008. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 44, 2425-2432. DOI |
9 | Marinova, E. K., D. B. Nikolova, D. N. Popova, G. B. Gallacher, and N. D. Ivanovska. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/C mice by berberine. Immunopharmacol. 48, 9-16. DOI |
10 | Shvarev, I. F. and A. L. Tsetlin. 1972. Anti-blastic properties of berberine and its derivatives. Farmakol. Toksikol. 35, 73-75. |
11 | Xu, Y., Y. Wang, and L. Yan. 2009. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J. Proteome Res. 8, 5296-5304. DOI |
12 | Yin, J., H. L. Xing, and J. P. Ye. 2008. Efficacy of berberine in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 57, 712-717. DOI ScienceOn |
13 | Yu, H. H., K. J. Kim, J. D. Cha, H. K. Kim, Y. E. Lee, N. Y. Choi, and Y. O, You. 2005. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food 8, 454-461. DOI |
14 | Ikram, M. 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 28, 353-358. DOI |
15 | Ivanovska, N. and S. Phillip. 1996. Study on the anti-inflammatory of Berveris vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol. 18, 553-561. DOI |
16 | Kim, S. M., Y. Kim, J. E. Kim, K. H. Cho, and J. H. Chung. 2008. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15, 340-347. DOI |
17 | Jantova, S., L. Cipak, M. Cernakova, and D. Kost'alova. 2003. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J. Pharm. Pharmacol. 55, 1143-1149. DOI |
18 | Kallapur, S. G. and A. H. Jobe. 2006. Contribution of inflammation to lung injury and development. Arch. Dis. Child. Fetal Neonatal. 91, 132-135. DOI |
19 | Kettmann, V., D. Kosfalova, S. Jantova, M. Cernakova, and J. Drimal. 2004. In vitro cytotoxicity of ververine against HeLa and L1210 cancer cell lines. Pharmazie 59, 548-551. |
20 | Kong, W. J., Z. Y. Zuo, Y. M. Wang, D. Q. Song, X. F. You, L. X. Zhao, H. N. Pan, and J. D. Jiang. 2008. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metab. Clin. Exp. 57, 1029-1037. DOI ScienceOn |
21 | Kuo, C. L., C. W. Chi, and T. Y. Liu. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203, 127-137. DOI |
22 | Lau, C. W., X. Q. Yao, Z. Y. Chen, W. H. Ko, and Y. Huang. 2001. Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 19, 234-244. DOI |